Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +48.09%
#3 Pons Pons +29.16%
#4 龙虾 (Lobster) 龙虾 (Lobster) +18.73%
#5 ADO Protocol ADO Protocol +18.06%
#6 Main Street Yield Main Street Yield +17.48%
#7 Collect on Fanable Collect on Fanable +16.65%
#8 OpenGradient OpenGradient +12.52%
#9 o1.exchange o1.exchange +12.13%
#10 Nillion Nillion +10.62%
Coin of the day
GEKKO GEKKO
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Inventiva S.A. Inventiva S.A.

Inventiva S.A.

IVA
Rang in Aktien #8990
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
Aktienkurs
$4.74
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$1.12B
Veränderung (1 Tag)
-5.77%
Veränderung (1 Jahr)
-16.96%
Land
FR
Handel Inventiva S.A. (IVA)

Kategorie

Healthcare
Aktien-Split-Historie für Inventiva S.A. (IVA)
Die Aktie Inventiva S.A. (Symbol: IVA) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 29, 2026 statt.
Eine IVA-Aktie, die vor dem Aug 29, 2026 gekauft wurde, entspricht heute 0 IVA-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH